Publications by authors named "Renato Tassi"

Claim this Profile
T
The national COVID-19 vaccination campaign targeting the extremely vulnerable: the Florence Medical Oncology Unit experience in patients with cancer.
Maria S Pino, Simone Cheli, Marco Perna, Valentina Fabbroni, Clara Giordano, Renato Tassi

Eur J Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vinorelbine in Non-Small Cell Lung Cancer: Real-World Data From a Single-Institution Experience.
Stefania Nobili, Daniele Lavacchi, Gabriele Perrone, Giulio Vicini, Renato Tassi

Oncol Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy.
Enrico Mini, Andrea Lapucci, Gabriele Perrone, Romina D'Aurizio, Cristina Napoli, Renato Tassi

Int J Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERRATUM.
Enrico Mini, Ida Landini, Laura Lucarini, Andrea Lapucci, Cristina Napoli, Renato Tassi

Oncol Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways.
Enrico Mini, Ida Landini, Laura Lucarini, Andrea Lapucci, Cristina Napoli, Renato Tassi

Oncol Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.
Marica Garziera, Ettore Bidoli, Erika Cecchin, Enrico Mini, Stefania Nobili, Renato Tassi

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma: Where are we?
Roberto Mazzanti, Umberto Arena, Renato Tassi

World J Exp Med· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging drugs in refractory colorectal cancer.
Stefania Nobili, Alessandro Galletta, Marco Brugia, Renato Tassi, Paolo Petreni

Future Med Chem· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperlipidemia and hypothyroidism among metastatic renal cell carcinoma patients taking sunitinib malate. Related or unrelated adverse events?
Renato Tassi, Valentina Baldazzi, Alberto Lapini, Marco Carini, Roberto Mazzanti

Clin Genitourin Cancer· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biweekly sunitinib regimen reduces toxicity and retains efficacy in metastatic renal cell carcinoma: a single-center experience with 31 patients.
Bruno Neri, Agnese Vannini, Marco Brugia, Andrea Muto, Sheila Rangan, Renato Tassi

Int J Urol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: a prospective single-center study.
Valentina Baldazzi, Renato Tassi, Alberto Lapini, Carmine Santomaggio, Marco Carini

Urol Oncol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sunitinib-induced hyperparathyroidism: a possible mechanism to altered bone homeostasis.
Valentina Baldazzi, Renato Tassi, Alberto Lapini, Alice Lunghi, Eleonora Garofoli

Cancer· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis